Since the implementation of CSAR, according to data from the National Medical Products Administration (NMPA), as shown in Figure 1, in 2021, 6 new cosmetic ingredients obtained NMPA numbers, of which 4 were for domestically produced new cosmetic ingredients and 2 for imported cosmetic ingredients. In 2022, 42 new cosmetic ingredients obtained NMPA numbers, with 25 being domestically produced and 17 being imported. As of December 15, 2023, 60 new cosmetic ingredients have obtained NMPA numbers, with 46 being domestically produced and 14 being imported.

Since the publication of the Cosmetics Supervision and Administration Regulations (CSAR, State Order No. 727) on June 29, 2020, a series of supporting regulations have also been introduced. Included among all the supporting regulations are those relating to the registration and filing of new cosmetic ingredients in China, namely the: Measures for the Administration of Cosmetic Registration and Filing; Provisions on the Administration of New Cosmetic Ingredients Registration (hereafter the Provisions); and Filing Data and Technical Guidelines for Cosmetics Safety Assessment.

En Chine, la sécurité des ingrédients cosmétiques est réglementée par la NMPA (Administration Nationale des Produits Médicaux) conformément au CSAR (Règlement sur la Supervision et l'Administration des Produits Cosmétiques). Un ingrédient est considéré comme "nouveau" s'il ne figure pas dans l'IECIC 2021 (Inventaire des Ingrédients Cosmétiques Existants en Chine). Les ingrédients existants en Chine doivent être répertoriés dans l'IECIC 2021, et leurs données de sécurité doivent être rapportées à la NMPA via la plateforme d'information de sécurité des ingrédients cosmétiques.

Recently, the National Medical Products Administration (NMPA) discovered that Japan HOYU Limited had violated the requirements of the Cosmetics Supervision and Administration Regulations (CSAR) and the Measures for the Supervision and Administration of Cosmetics Production and Operation in an unannounced inspection. The enterprise has changed the production process of its products without obtaining the authorisation, and is suspected of not producing cosmetics in accordance with the technical requirements stated in the cosmetics registration documents.

To implement the Cosmetics Supervision and Administration Regulations (CSAR) and the Measures for the Supervision and Administration of Cosmetics Production and Operation, the National Medical Products Administration (NMPA) has organized to draft the Measures for the Administration of Cosmetics Inspection and released it for public consultation. Any comments are welcomed between October 19 and November 10, 2023.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

To regulate the administration of toothpaste products and safeguard the health of consumers, China's National Medical Products Administration (NMPA) published a notice on fully implementing the requirements of toothpaste administration regulation and simplifying the documents requirements for toothpaste that has already been placed on the market.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Beijing Cosmetics Review and Inspection Center and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.